82077 CPT® code: payer coverage and prior authorization82077 appears in 6 coverage policies from Blue Cross Blue Shield of Massachusetts, Blue Cross NC, Blue Shield of California, Centene, Cigna, Health Care Service Corporation (BCBS IL, TX, OK, NM, MT).
| Payer | Policy | Role in policy | Reviewed | Document |
|---|---|---|---|---|
| Blue Cross Blue Shield of Massachusetts | Drug Testing in Pain Management and Treatment of Substance Use Disorders (674) | listed, no stance | payer document | |
| Blue Cross NC | Professional Pathology Billing Requirements AHS – R2169 | listed, no stance (range 82009-82958) | Mar 1, 2024 | payer document |
| Blue Shield of California | Drug Testing in Pain Management and Substance Use Disorder Treatment (2.04.98) | listed, no stance | payer document | |
| Centene | Drugs of Abuse: Definitive Testing (CP.MP.50) | covered if criteria are met | Jun 1, 2023 | payer document |
| Cigna | Laboratory Testing Services (0604) | not covered | May 15, 2026 | payer document |
| Health Care Service Corporation (BCBS IL, TX, OK, NM, MT) | Drug Testing in Pain Management and Substance Use Disorder Treatment (MED207.154) CPT Codes 80156, 80188, 80299, 80305, 80306, 80307, 80320, 80321, 80322, | listed, no stance | Jan 1, 2026 | payer document |
From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.